Q2 was another strong quarter with ARR growing 22%. Before I go into the details, I want to take a step back and provide my perspective on the position Guidewire Software, Inc. occupies in our ...

Late-stage gene therapy pipeline for rare and retinal diseases advancing toward key catalysts RGX-202 for Duchenne muscular dystrophy: New Phase I/II data at ...

Late-stage gene therapy pipeline for rare and retinal diseases advancing toward key catalysts RGX-202 for Duchenne muscular dystrophy: New Phase I/II data ...

Maths exam can make the toppers fret and sweat. This we know is an established truth. It is almost again that time of the year again for Class 12th st.